MIRD pamphlet No. 21: A generalized schema for radiopharmaceutical dosimetry-standardization of nomenclature

Journal of Nuclear Medicine

Volumn 50, Issue 3, 2009, Pages 477-484

  Bolch, Wesley E ^a   Eckerman, Keith F ^b   Sgouros, George ^c   Thomas, Stephen R ^d   Brill, A Bertrand ^e   Fisher, Darrell R ^e   Howell, Roger W ^e   Meredith, Ruby ^e   Wessels, Barry W ^e  

^a UNIVERSITY OF FLORIDA   (United States)

^b OAK RIDGE NATIONAL LABORATORY   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d UNIVERSITY OF CINCINNATI   (United States)

^e NONE

Author keywords

Absorbed dose; Effective dose; Equivalent dose; ICRP schema; MIRD schema

Indexed keywords

ARTICLE; DOSIMETRY; IONIZING RADIATION; PRIORITY JOURNAL; RADIATION ENERGY; RADIATION EXPOSURE; RADIATION PROTECTION;

ALGORITHMS; HUMANS; RADIATION DOSAGE; RADIOPHARMACEUTICALS; RELATIVE BIOLOGICAL EFFECTIVENESS; STOCHASTIC PROCESSES; TERMINOLOGY AS TOPIC;

EID: 62449175592     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.108.056036     Document Type: Article

References (46)

1. Loevinger R, Berman M. A Revised Schema for Calculating the Absorbed Dose from Biologically Distributed Radionuclides. MIRD Pamphlet No. 1. Revised ed. New York, NY: Society of Nuclear Medicine; 1976.
2. Loevinger R. Berman M. A formalism for calculation of absorbed dose from radionuclides. Phys Med Biol. 1968;13:205-217.
3. Loevinger R. Berman M. A Schema for Absorbed-Dose Calculations for Biologically-Distributed Radionuclides. MIRD Pamphlet No. 1. New York, NY: Society of Nuclear Medicine; 1968.
4. Loevinger R, Budinger TF, Watson EE. MIRD Primer for Absorbed Dose Calculations. Revised ed. New York, NY: The Society of Nuclear Medicine; 1991.
5. Bolch WE, Bouchet LG, Robertson JS, et al. MIRD pamphlet no. 17: the dosimetry of nonuniform activity distributions: radionuclide S values at the voxel level. J Nucl Med. 1999;40(suppl): 11S-36S.
6. Howell RW, Wessels BW. Loevinger R. The MIRD perspective 1999. J Nucl Med. 1999;40(suppl):3S-10S.
7. International Commission on Radiological Protection (ICRP). 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. New York, NY: Pergamon Press; 1991.
8. International Commission on Radiological Protection (ICRP). 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103. Ann ICRP. 2007;37:1-332.
9. International Commission on Radiation Units and Measurements (ICRU). Fundamental Quantities and Units for Ionizing Radiation. Report 60. Bethesda, MD: ICRU; 1998.
10. Snyder WS, Ford MR, Wamer GG, Watson SB. A Tabulation of Dose Equivalent per Microcurie-Day for Source and Target Organs of an Adult for Various Radionuclides. ORNL/TM-5000. Oak Ridge, TN: Oak Ridge National Laboratory; 1974.
11. Snyder WS, Ford MR, Warner GG, Watson SB. "S," Absorbed Dose per Unit Cumulated Activity for Selected Radionuclides and Organs. MIRD Pamphlet No. 11. New York, NY: Society of Nuclear Medicine; 1975.
12. Zaidi H, Xu XG. Computational anthropomorphic models of the human anatomy: the path to realistic Monte Carlo modeling in radiological sciences. Annu Rev Blamed Eng. 2007;9:471-500.
13. Goddu SM, Howell RW, Bouchet LG, Bolch WE, Rao DV. MIRD Cellular S Values: Self Absorbed Dose per Unit Cumulated Activity for Selected Radionuclides and Monoenergetic Electron and Alpha Particle Emitters Incorporated into Different Cell Compartments. Reston, VA: Society of Nuclear Medicine: 1997.
14. Eckerman KF, Endo A. MIRD: Radionuclide Data and Decay Schemes. 1st ed. Reston, VA: Society of Nuclear Medicine; 2008.
15. Humm JL. Howell RW, Rao DV. Dosimetry of Auger-electron-emitting radionuclides: report no. 3 of AAPM Nuclear Medicine Task Group No. 6. Med Phys. 1994;21:1901-1915.
16. Howell RW, Narra VR, Sastry KSR. Rao DV. On the equivalent dose for Auger electron emitters. Radial Res. 1993;134:71-78.
17. International Commission on Radiological Protection (ICRP). Recommendations of the International Commission on Radiological Protection, ICRP Publication 26. Oxford, U.K.: Pergamon Press; 1977.
18. International Commission on Radiological Protection (ICRP). Limits for Intakes of Radionuclides by Workers. ICRP Publication 30 (Part 1). Oxford, U.K.: ICRP; 1979.
19. International Commission on Radiological Protection (ICRP). Age-Dependent Doses to Members of the Public from Intake of Radionuclides: Part 5 - Compilation of Ingestion and Inhalation Dose Coefficients. ICRP Publication 72. Elmsford. NY: ICRP; 1996.
20. Harrison JD, Streffer C. The ICRP protection quantities, equivalent and effective dose: their basis and application. Radiat Prot Dosimetry. 2007;127:12-18.
21. Poston JW. Application of the effective dose equivalent to nuclear medicine patients. J Nucl Med. 1993;34:714-716.
22. International Commission on Radiological Protection (ICRP). Basic Anatomical and Physiological Data for Use in Radiological Protection: Reference Values. ICRP Publication 89. Oxford, U.K.: Pergamon Press; 2002.
23. Feinendegen LE, McClure JJ. Alpha-emitters for medical therapy: workshop of the United States Department of Energy. Radiat Res. 1997;148:195-201.
24. 90Y-labeled CO] 7-1A Fab′ fragments in a human colonic cancer model. Cancer Res. 1999;59:2635-2643.
25. 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an α-emitter in vivo. J Nucl Med. 2005;46:2061-2067.
26. 60Co irradiation in nude mice. J Nucl Med. 2005;46:464-471.
27. Sgouros G. Song H, Ladenson PW, Wahl RL. Lung toxicity in radioiodine therapy of thyroid carcinoma: development of a dose-rate method and dosi metric implications of the 80-mCi rule. J Nucl Med. 2006;47:1977-1984.
28. International Commission on Radiological Protection (ICRP). ICRP publication 58: RBE for deterministic effects. Ann ICRP. 1991;21:1-100.
29. International Commission on Radiological Protection (ICRP). ICRP publication 92: relative biological effectiveness (RBE), quality factor (Q), and radiation weighting factor (wR). Ann ICRP. 2004;33:1-121.
30. International Commission on Radiation Units and Measurements (ICRU). Absorbed Dose Specification in Nuclear Medicine. Report 67. Bethesda, MD:ICRU; 2002.
31. National Council on Radiation Protection and Measurements (NCRP). The Relative Biological Effectiveness of Radiations of Different Quality. Report No. 104. Bethesda, MD: NCRP; 1990.
32. National Council on Radiation Protection and Measurements (NCRP). Operational Radiation Safety Program for Astronauts in Low-Earth Orbit: A Basic Framework. Report No. 142. Bethesda, MD: NCRP; 2002.
33. Hall EJ. Radiation dose-rate: a factor of importance in radiobiology and radiotherapy. Br J Radiol. 1972;45:81-97.
34. Barendsen GW. Dose fractionation, dose rale and iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys. 1982;8:1981-1997.
35. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 1989;62:679-694.
36. Fowler JF. Radiobiological aspects of low dose rates in radioimmunotherapy. Int J Radiat Oncol Biol Phys. 1990;18:1261-1269.
37. Dale RG. Dose-rate effects in targeted radiotherapy. Phys Med Biol. 1996;41:1871-1884.
38. Dale R, Carabe-Fernandez A. The radiobiology of conventional radiotherapy and its application to radionuclide therapy. Cancer Biother Radiopharm. 2005;20:47-51.
39. Behr TM, Memtsoudis S, Sharkey RM, et al. Experimental studies on the role of antibody fragments in cancer radio-immunotherapy: influence of radiation dose and dose rate on toxicity and anti-tumor efficacy. Int J Cancer. 1998;77:787-795.
40. Flynn AA, Pedley RB, Green AJ, et al. Effectiveness of radiolabeled antibodies for radio-immunotherapy in a colorectal xenograft model: a comparative study using the linear-quadratic formulation. Int J Radiat Biol. 2001;77:507-517.
41. Rao DV, Howell RW. Time dose fractionation in radioimmunotherapy: implications for selecting radionuclides. J Nucl Med. 1993;34:1801-1810.
42. Howell RW. Goddu SM. Rao DV. Application of the linear-quadratic model to radioimmunotherapy: further support for the advantage of longer-lived radionuclides. J Med. 1994;35:1861-1869.
43. Niemierko A. Reporting and analyzing dose distributions: a concept of equivalent uniform dose. Med Phys. 1997;24:103-110.
44. Kulcher GJ, Burman C, Brewster L. Goitein M, Mohan R. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys. 1991;21:137-146.
45. O'Donoghue JA. Implications of nonuniform tumor doses for radioimmunotherapy. J Nucl Med. 1999;40:1337-1341.
46. Wambersie A, Hendry JH, Andreo P, et al. The RBE issues in ion-beam therapy: conclusions of a joint 1AEAJICRU working group regarding quantities and units. Radiat Prot Dosimetry, 2006;122:463-470.